Summary
Background
Crimean-Congo hemorrhagic fever (CCHF) is a tick-borne disease that has various symptoms. Since rapid diagnosis is crucial for survival, understanding the characteristics of patients is important for clinicians while waiting for results. This study aimed to evaluate findings that support the preliminary diagnosis of suspected CCHF in patients and take a look at the management of CCHF in Turkey.
Methods
Demographics, presenting symptoms and laboratory findings of the patients admitted with a suspicion of CCHF, were recorded from the patient files and database of Ministry of Health. A diagnosis of CCHF was based on detection of immunoglobulin M (IgM) antibodies and/or viral RNA. The patients with and without CCHF were compared in terms of differences in epidemiological, clinical and laboratory findings.
Results
Out of 87 patients, 61 (70.1%) were CCHF and 26 (29.9%) were non-CCHF cases. Working with agriculture/livestock, tick exposure, contact with body fluids of animals, travel to rural areas within 2 weeks, fever, headache, leucopenia, anemia, international normalized ratio (INR) elevation were significantly more common in CCHF cases. According to multivariate analysis, tick exposure (odds ratio, OR 9.03, 95% confidence interval, CI 1.96–41.47, p = 0.005), contact with body fluids of animals (OR 14.9, 95% CI 2.23–99.94, p = 0.005), leucopenia (OR 13.65, 95% CI 2.55–72.91, p = 0.02) and anemia (OR 8.41, 95% CI 1.06–66.42, p = 0.04) were independently indicative for CCHF.
Conclusion
As it takes a considerable time for a definitive diagnosis, determining epidemiological features and risk factors is an important step for preliminary diagnosis of CCHF as well as early implementation of precautions against nosocomial transmission of the virus.
Similar content being viewed by others
References
Al-Abri SS, Abaidani IA, Fazlalipour M, et al. Current status of Crimean-Congo haemorrhagic fever in the World Health Organization Eastern Mediterranean Region: issues, challenges, and future directions. Int J Infect Dis. 2017;58:82–9.
Messina JP, Pigott DM, Golding N, et al. The global distribution of Crimean-Congo hemorrhagic fever. Trans R Soc Trop Med Hyg. 2015;109:503–13.
Koculu S, Oncul A, Onal O, et al. Evaluation of knowledge of the healthcare personnel working in Giresun province regarding Crimean-Congo hemorrhagic fever before and after educational training. J Vector Borne Dis. 2015;52(2):166–70.
Ergonul O. Crimean-Congo haemorrhagic fever. Lancet Infect Dis. 2006;6:203–14.
Kilinc C, Gückan R, Capraz M, et al. Examination of the specific clinical symptoms and laboratory findings of Crimean-Congo hemorrhagic fever. J Vector Borne Dis. 2016;53(2):162–7.
Papa A, Bino S, Llagami A, et al. Crimean-Congo hemorrhagic fever in Albania, 2001. Eur J Clin Microbiol Infect Dis. 2002;21:603–6.
Karti SS, Odabasi Z, Korten V, et al. Crimean-Congo hemorrhagic fever in Turkey. Emerg Infect Dis. 2004;10:1379–84.
Grard G, Drexler JF, Fair J, et al. Re-emergence of Crimean-Congo hemorrhagic fever virus in Central Africa. PLoS Negl Trop Dis. 2011;5:1350.
Leblebicioglu H, Ozaras R, Irmak H, et al. Crimean-Congo hemorrhagic fever in Turkey: current status and future challenges. Antiviral Res. 2016;126:21–34.
Hsgm.saglik.gov.tr. KKKA Istatistik verileri.. https://hsgm.saglik.gov.tr/tr/zoonotikvektorel-kkka/zoonotikvektorel-kkka-istatistik. Accessed 9 Oct 2018.
Estrada-Pena A, Zatansever Z, Gargili A, et al. Modeling the spatial distribution of crimean-congo hemorrhagic fever outbreaks in Turkey. Vector Borne Zoonotic Dis. 2007;7:667–78.
Duran A, Küçükbayrak A, Ocak T, et al. Evaluation of patients with Crimean-Congo hemorrhagic fever in Bolu, Turkey. Afr Health Sci. 2013;13(2):233–42.
Hekimoğlu HC, Demirci NA. Evaluation of cases with a preliminary diagnosis of Crimean-Congo hemorrhagic fever and comparison of characteristics in patients admitted to a secondary care hospital in Kastamonu, Turkey. Afr Health Sci. 2014;14(4):873–81.
Yilmaz GR, Buzgan T, Irmak H, et al. The epidemiology of Crimean-Congo hemorrhagic fever in Turkey, 2002–2007. Int J Infect Dis. 2009;13(3):380–6.
Sisman A. Epidemiologic features and risk factors of Crimean-Congo hemorrhagic fever in Samsun province, Turkey. J Epidemiol. 2013;23(2):95–102.
Ozkurt Z, Kiki I, Erol S, et al. Crimean-Congo hemorrhagic fever in Eastern Turkey: clinical features, risk factors and efficacy of ribavirin therapy. J Infect. 2006;52:207–15.
Vorou R, Pierroutsakos IN, Maltezou HC. Crimean-Congo hemorrhagic fever. Curr Opin Infect Dis. 2007;20:495–500.
Izadi S, Holakouie-Naieni K, Majdzadeh SR, et al. Seroprevalence of Crimean-Congo hemorrhagic fever in Sistan-va-Baluchestan Province of Iran. Jpn J Infect Dis. 2006;59:326–8.
Akyazi R, Ecevit O. Ticks and Crimean Congo hemorrhagic fever. J Agric OMU. 2006;21(3):340–9.
Mardani M, Keshtkar-Jahromi M. Crimean Congo hemorrhagic fever. Arch Iran Med. 2007;10:204–14.
Ergönül O, Celikbaş A, Dokuzoguz B, et al. Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy. Clin Infect Dis. 2004;39:284–7.
Izadi S, Naieni KH, Madjdzadeh SR, et al. Crimean-Congo hemorrhagic fever in Sistan and Baluchestan Province of Iran, a case-control study on epidemiological characteristics. Int J Infect Dis. 2004;8:299–306.
Bakir M, Ugurlu M, Dokuzoguz B, Turkish CCHF Study Group, et al. Crimean-Congo haemorrhagic fever outbreak in Middle Anatolia: a multicentre study of clinical features and outcome measures. J Med Microbiol. 2005;54(4):385–9.
Yilmaz GR, Buzgan T, Torunoglu MA, et al. A preliminary report on Crimean-Congo haemorrhagic fever in Turkey, March–June 2008. Euro Surveill. 2008;13:189.
Mostafavi E, Pourhossein B, Chinikar S. Clinical symptoms and laboratory findings supporting early diagnosis of Crimean-Congo hemorrhagic fever in Iran. J Med Virol. 2014;86:1188–92.
Bente DA, Forrester NL, Watts DM, et al. Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity. Antiviral Res. 2013;100:159–89.
Mertens M, Schmidt K, Ozkul A, et al. The impact of Crimean-Congo hemorrhagic fever virus on public health. Antiviral Res. 2013;98:248–60.
Erenler AK, Kulaksiz F, Ülger H, et al. Predictors of Crimean-Congo hemorrhagic fever in the emergency department. Eur Rev Med Pharmacol Sci. 2015;19(20):3811–6.
Papa A, Christova I, Papadimitriou E, et al. Crimean-Congo hemorrhagic fever in Bulgaria. Emerg Infect Dis. 2004;10:1465–7.
Schwarz TF, Nsanze H, Ameen AM. Clinical features of Crimean-Congo haemorrhagic fever in the United Arab Emirates. Infection. 1997;25:364–7.
Cevik MA, Erbay A, Bodur H, et al. Clinical and laboratory features of Crimean-Congo hemorrhagic fever: predictors of fatality. Int J Infect Dis. 2008;12:374–9.
Frangoulidis D, Meyer H. Measures undertaken in the German Armed Forces Field Hospital deployed in Kosovo to contain a potential outbreak of Crimean-Congo hemorrhagic fever. Mil Med. 2005;170:366–9.
Tezer H, Sucakli IA, Sayli TR, et al. I Crimean-Congo hemorrhagic fever in children. J Clin Virol. 2010;48:184–6.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Z. Yeşilbağ, A. Karadeniz, S. Koçulu, and C.B. Kayhan declare that they have no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Yeşilbağ, Z., Karadeniz, A., Koçulu, S. et al. Epidemiological characteristics, clinical and laboratory findings supporting preliminary diagnosis of Crimean-Congo hemorrhagic fever in an endemic region in Turkey. Wien Klin Wochenschr 132, 581–588 (2020). https://doi.org/10.1007/s00508-020-01719-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00508-020-01719-5